Loading...
The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus
BACKGROUND: Sodium glucose co‐transporter 2 (SGLT2) inhibitors are a new class of pharmacologic agents developed for the treatment of type 2 diabetes mellitus (T2DM). Their unique mechanism of action is independent of pancreatic beta‐cell function or the degree of insulin resistance, giving these ag...
Saved in:
| Published in: | Int J Clin Pract |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758393/ https://ncbi.nlm.nih.gov/pubmed/26147213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|